MTP 014 Clinical questions to be addressed: Are the current recommendations for screening for cardiovascular disease in patients with diabetes too conservative? Is there evidence for the value of pre-symptomatic screening (other than lipids) in the prevention of cardiovascular events? Which tests should be performed? What about hs-CRP? How if at all should screening, prevention, and treatment guidelines differ for patients with type 1 diabetes from those with type 2?